{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T09:12:05Z","timestamp":1772788325829,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T00:00:00Z","timestamp":1614211200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T00:00:00Z","timestamp":1614211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002714","name":"Albert-Ludwigs-Universit\u00e4t Freiburg","doi-asserted-by":"publisher","award":["Berta-Ottenstein-Programme for Advanced Clinician Scientists"],"award-info":[{"award-number":["Berta-Ottenstein-Programme for Advanced Clinician Scientists"]}],"id":[{"id":"10.13039\/501100002714","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Skeletal-related events (SREs) due to bone metastases (BM) significantly impact the morbidity and mortality of cancer patients. The present study sought to investigate clinicopathological characteristics, metastasis-free survival (MFS), and SREs in patients referred to a tertiary orthopedic and trauma center.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Data were retrieved from electronic health records (<jats:italic>n<\/jats:italic>=628). Survival curves were estimated utilizing the Kaplan\u2013Meier method. The Cox regression model was used to determine factors influencing MFS based on estimated hazard ratios (HRs).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Breast (55.8%) and lung (18.2%), and lung (32.9%) and prostate (16.8%) cancer were the most common cancer types in our cohort in women and men, respectively. Fifteen percent of patients presented with BM as the first manifestation of tumor disease, 23% had metastasis diagnosis on the same day of primary tumor diagnosis or within 3\u2009months, and 62% developed BM at least 3\u2009months after primary tumor diagnosis. Osteolytic BM were predominant (72.3%) and most commonly affecting the spine (23%). Overall median MFS was 45\u2009months (32 (men) vs. 53 (women) months). MFS was shortest in the lung (median 15\u2009months, 95% CI 8.05\u201319) and longest in breast cancer (median 82\u2009months, 95% CI 65.29\u201394). Age (\u2265 60 vs. &lt;\u200960\u2009years) and primary cancer grading of \u22652 vs. 1 revealed prognostic relevance.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Women with breast or lung cancer, men with lung or prostate cancer, age \u226560\u2009years, male sex, and primary cancer grading \u22652 are associated with increased risk for MBD. Intensified follow-up programs may reduce the risk of SREs and associated morbidity and mortality.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12957-021-02169-7","type":"journal-article","created":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T14:09:41Z","timestamp":1614262181000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Clinicopathologic characteristics, metastasis-free survival, and skeletal-related events in 628 patients with skeletal metastases in a tertiary orthopedic and trauma center"],"prefix":"10.1186","volume":"19","author":[{"given":"Georg","family":"Herget","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2298-3696","authenticated-orcid":false,"given":"Babak","family":"Saravi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenia","family":"Schwarzkopf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara","family":"Wigand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"S\u00fcdkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hagen","family":"Schmal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Uhl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gernot","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,25]]},"reference":[{"key":"2169_CR1","unstructured":"AAOS, Metastatic bone disease, 2020. https:\/\/orthoinfo.aaos.org\/en\/diseases%2D%2Dconditions\/metastatic-bone-disease\/. (Accessed 27.03.2020 2020)., n.d. https:\/\/orthoinfo.aaos.org\/en\/diseases\u2013conditions\/metastatic-bone-disease\/."},{"key":"2169_CR2","first-page":"71","volume":"108","author":"KS Delank","year":"2011","unstructured":"Delank KS, Wendtner C, Eich HT, Eysel P. The treatment of spinal metastases. Dtsch Arztebl Int. 2011;108:71\u2013980.","journal-title":"Dtsch Arztebl Int"},{"issue":"6","key":"2169_CR3","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1002\/jor.24660","volume":"38","author":"TA Damron","year":"2020","unstructured":"Damron TA, Mann KA. Fracture risk assessment and clinical decision making for patients with metastatic bone disease. J Orthop Res. 2020;38(6):1175.","journal-title":"J Orthop Res"},{"key":"2169_CR4","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.critrevonc.2005.03.011","volume":"56","author":"G Selvaggi","year":"2005","unstructured":"Selvaggi G, Scagliotti GV. Management of bone metastases in cancer: a review. Crit Rev Oncol Hematol. 2005;56:365\u201378.","journal-title":"Crit Rev Oncol Hematol"},{"key":"2169_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s10195-015-0344-0","volume":"16","author":"A Piccioli","year":"2015","unstructured":"Piccioli A, Maccauro G, Spinelli MS, Biagini R, Rossi B. Bone metastases of unknown origin: epidemiology and principles of management. J Orthop Traumatol. 2015;16:81\u20136.","journal-title":"J Orthop Traumatol"},{"key":"2169_CR6","first-page":"0129428","volume":"10","author":"T Takagi","year":"2015","unstructured":"Takagi T, Katagiri H, Kim Y, Suehara Y, Kubota D, Akaike K, et al. Skeletal metastasis of unknown primary origin at the initial visit: a retrospective analysis of 286 cases. PLoS One. 2015;10:0129428.","journal-title":"PLoS One"},{"key":"2169_CR7","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1097\/CORR.0000000000000434","volume":"477","author":"CJ Gutowski","year":"2019","unstructured":"Gutowski CJ, Zmistowski B, Fabbri N, Boland PJ, Healey JH. Should the use of biologic agents in patients with renal and lung cancer affect our surgical management of femoral metastases? Clin Orthop Relat Res. 2019;477:707\u201314.","journal-title":"Clin Orthop Relat Res"},{"key":"2169_CR8","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.clbc.2017.08.012","volume":"18","author":"B Rogoz","year":"2018","unstructured":"Rogoz B, l\u2019Aulnoit AH, Duhamel A, de\u2019l Aulnoit DH. Thirty-year trends of survival and time-varying effects of prognostic factors in patients with metastatic breast cancer-a single institution experience. Clin Breast Cancer. 2018;18:246\u201353.","journal-title":"Clin Breast Cancer"},{"key":"2169_CR9","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s10549-011-1475-5","volume":"129","author":"M Yong","year":"2011","unstructured":"Yong M, Jensen AO, Jacobsen JB, Norgaard M, Fryzek JP, Sorensen HT. Survival in breast cancer patients with bone metastases and skeletal-related events: a population-based cohort study in Denmark (1999-2007). Breast Cancer Res Treat. 2011;129:495\u2013503.","journal-title":"Breast Cancer Res Treat"},{"key":"2169_CR10","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/S1470-2045(12)70211-5","volume":"13","author":"F Bray","year":"2012","unstructured":"Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the human development index (2008-2030): a population-based study. Lancet Oncol. 2012;13:790\u2013801.","journal-title":"Lancet Oncol"},{"key":"2169_CR11","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.juro.2010.03.034","volume":"184","author":"M Norgaard","year":"2010","unstructured":"Norgaard M, Jensen AO, Jacobsen JB, Cetin K, Fryzek JP, Sorensen HT. Skeletal related events, bone metastasis and survival of prostate cancer: a population based cohort study in Denmark (1999 to 2007). J Urol. 2010;184:162\u20137.","journal-title":"J Urol"},{"key":"2169_CR12","doi-asserted-by":"crossref","unstructured":"Brierley JD, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. 8th ed: Wiley-Blackwell; 2016.","DOI":"10.1002\/9780471420194.tnmc26.pub3"},{"key":"2169_CR13","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/0046-8177(92)90108-F","volume":"23","author":"DF Gleason","year":"1992","unstructured":"Gleason DF. Histologic grading of prostate cancer: a perspective. Hum Pathol. 1992;23:273\u20139.","journal-title":"Hum Pathol"},{"key":"2169_CR14","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/jama.280.11.969","volume":"280","author":"AV D\u2019Amico","year":"1998","unstructured":"D\u2019Amico AV. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998;280:969. https:\/\/doi.org\/10.1001\/jama.280.11.969.","journal-title":"JAMA."},{"key":"2169_CR15","doi-asserted-by":"publisher","first-page":"6243s","DOI":"10.1158\/1078-0432.CCR-06-0931","volume":"12","author":"RE Coleman","year":"2006","unstructured":"Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006;12:6243s\u20139s. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-0931.","journal-title":"Clin Cancer Res"},{"key":"2169_CR16","doi-asserted-by":"publisher","first-page":"482","DOI":"10.21037\/atm.2020.03.55","volume":"8","author":"J-F Huang","year":"2020","unstructured":"Huang J-F, Shen J, Li X, Rengan R, Silvestris N, Wang M, et al. Incidence of patients with bone metastases at diagnosis of solid tumors in adults: a large population-based study. Ann Transl Med. 2020;8:482. https:\/\/doi.org\/10.21037\/atm.2020.03.55.","journal-title":"Ann Transl Med"},{"key":"2169_CR17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/JTO.0b013e31819518fc","volume":"4","author":"H Al Husaini","year":"2009","unstructured":"Al Husaini H, Wheatley-Price P, Clemons M, Shepherd FA. Prevention and management of bone metastases in lung cancer: a review. J Thorac Oncol. 2009;4:251\u20139. https:\/\/doi.org\/10.1097\/JTO.0b013e31819518fc.","journal-title":"J Thorac Oncol"},{"key":"2169_CR18","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1002\/(sici)1097-0142(19971015)80:8+<1588::aid-cncr9>3.3.co;2-z","volume":"80","author":"RE Coleman","year":"1997","unstructured":"Coleman RE. Skeletal complications of malignancy. Cancer. 1997;80:1588\u201394. https:\/\/doi.org\/10.1002\/(sici)1097-0142(19971015)80:8+<1588::aid-cncr9>3.3.co;2-z.","journal-title":"Cancer"},{"key":"2169_CR19","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4103\/0970-2113.106127","volume":"30","author":"N Sathiakumar","year":"2013","unstructured":"Sathiakumar N, Delzell E, Morrisey MA, Falkson C, Yong M, Chia V, et al. Mortality following bone metastasis and skeletal-related events among patients 65\u2009years and above with lung cancer: a population-based analysis of U.S. Medicare beneficiaries, 1999-2006. Lung India. 2013;30:20\u20136. https:\/\/doi.org\/10.4103\/0970-2113.106127.","journal-title":"Lung India"},{"key":"2169_CR20","doi-asserted-by":"publisher","first-page":"321","DOI":"10.4081\/oncol.2017.321","volume":"11","author":"F Macedo","year":"2017","unstructured":"Macedo F, Ladeira K, Pinho F, Saraiva N, Bonito N, Pinto L, et al. Bone metastases: an overview. Oncol Rev. 2017;11:321. https:\/\/doi.org\/10.4081\/oncol.2017.321.","journal-title":"Oncol Rev"},{"key":"2169_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jbo.2018.09.009","volume":"13","author":"TD Christensen","year":"2018","unstructured":"Christensen TD, Jensen SG, Larsen FO, Nielsen DL. Systematic review: incidence, risk factors, survival and treatment of bone metastases from colorectal cancer. J Bone Oncol. 2018;13:97\u2013105. https:\/\/doi.org\/10.1016\/j.jbo.2018.09.009.","journal-title":"J Bone Oncol"},{"key":"2169_CR22","doi-asserted-by":"publisher","first-page":"164","DOI":"10.5230\/jgc.2014.14.3.164","volume":"14","author":"FP Turkoz","year":"2014","unstructured":"Turkoz FP, Solak M, Kilickap S, Ulas A, Esbah O, Oksuzoglu B, et al. Bone metastasis from gastric cancer: the incidence, clinicopathological features, and influence on survival. J Gastric Cancer. 2014;14:164. https:\/\/doi.org\/10.5230\/jgc.2014.14.3.164.","journal-title":"J Gastric Cancer"},{"key":"2169_CR23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12885-017-3922-0","volume":"18","author":"RK Hernandez","year":"2018","unstructured":"Hernandez RK, Wade SW, Reich A, Pirolli M, Liede A, Lyman GH. Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States. BMC Cancer. 2018;18:44. https:\/\/doi.org\/10.1186\/s12885-017-3922-0.","journal-title":"BMC Cancer"},{"key":"2169_CR24","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s10549-016-3782-3","volume":"156","author":"A Liede","year":"2016","unstructured":"Liede A, Jerzak KJ, Hernandez RK, Wade SW, Sun P, Narod SA. The incidence of bone metastasis after early-stage breast cancer in Canada. Breast Cancer Res Treat. 2016;156:587\u201395. https:\/\/doi.org\/10.1007\/s10549-016-3782-3.","journal-title":"Breast Cancer Res Treat"},{"key":"2169_CR25","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s10549-009-0510-2","volume":"120","author":"R Yerushalmi","year":"2010","unstructured":"Yerushalmi R, Woods R, Kennecke H, Speers C, Knowling M, Gelmon K. Patterns of relapse in breast cancer: changes over time. Breast Cancer Res Treat. 2010;120:753\u20139. https:\/\/doi.org\/10.1007\/s10549-009-0510-2.","journal-title":"Breast Cancer Res Treat"},{"key":"2169_CR26","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.lungcan.2014.08.022","volume":"86","author":"K Cetin","year":"2014","unstructured":"Cetin K, Christiansen CF, Jacobsen JB, N\u00f8rgaard M, S\u00f8rensen HT. Bone metastasis, skeletal-related events, and mortality in lung cancer patients: a Danish population-based cohort study. Lung Cancer. 2014;86:247\u201354. https:\/\/doi.org\/10.1016\/j.lungcan.2014.08.022.","journal-title":"Lung Cancer"},{"key":"2169_CR27","doi-asserted-by":"publisher","unstructured":"V.M. Chia, K. Cetin, J.B. Jacobsen, M N\u2205rgaard, A.\u00d8. Jensen, C.F. Christiansen, H.T. S\u2205rensen, The incidence and prognostic significance of bone metastases and skeletal-related events in lung cancer patients: a population-based cohort study in Denmark., JCO. 28 (2010) e18074\u2013e18074. https:\/\/doi.org\/10.1200\/jco.2010.28.15_suppl.e18074.","DOI":"10.1200\/jco.2010.28.15_suppl.e18074"},{"key":"2169_CR28","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.canep.2014.05.005","volume":"38","author":"M Harries","year":"2014","unstructured":"Harries M, Taylor A, Holmberg L, Agbaje O, Garmo H, Kabilan S, et al. Incidence of bone metastases and survival after a diagnosis of bone metastases in breast cancer patients. Cancer Epidemiol. 2014;38:427\u201334. https:\/\/doi.org\/10.1016\/j.canep.2014.05.005.","journal-title":"Cancer Epidemiol"},{"key":"2169_CR29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2407-11-29","volume":"11","author":"A\u00d8 Jensen","year":"2011","unstructured":"Jensen A\u00d8, Jacobsen JB, N\u00f8rgaard M, Yong M, Fryzek JP, S\u00f8rensen HT. Incidence of bone metastases and skeletal-related events in breast cancer patients: a population-based cohort study in Denmark. BMC Cancer. 2011;11:29. https:\/\/doi.org\/10.1186\/1471-2407-11-29.","journal-title":"BMC Cancer"},{"key":"2169_CR30","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1093\/ije\/dys142","volume":"41","author":"JP Vandenbroucke","year":"2012","unstructured":"Vandenbroucke JP, Pearce N. Incidence rates in dynamic populations. Int J Epidemiol. 2012;41:1472\u20139. https:\/\/doi.org\/10.1093\/ije\/dys142.","journal-title":"Int J Epidemiol"},{"key":"2169_CR31","doi-asserted-by":"publisher","first-page":"539","DOI":"10.11622\/smedj.2014138","volume":"55","author":"VA Singh","year":"2014","unstructured":"Singh VA, Haseeb A, Alkubaisi AAHA. Incidence and outcome of bone metastatic disease at university Malaya medical Centre. Singap Med J. 2014;55:539\u201346. https:\/\/doi.org\/10.11622\/smedj.2014138.","journal-title":"Singap Med J"},{"key":"2169_CR32","doi-asserted-by":"publisher","first-page":"535","DOI":"10.6061\/clinics\/2015(08)01","volume":"70","author":"B Y\u00fccel","year":"2015","unstructured":"Y\u00fccel B, Celasun MG, \u00d6ztoprak B, Hasbek Z, Bahar S, Ka\u00e7an T, et al. The negative prognostic impact of bone metastasis with a tumor mass. Clinics (Sao Paulo). 2015;70:535\u201340. https:\/\/doi.org\/10.6061\/clinics\/2015(08)01.","journal-title":"Clinics (Sao Paulo)"},{"key":"2169_CR33","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1007\/s00198-013-2530-3","volume":"24","author":"R Rizzoli","year":"2013","unstructured":"Rizzoli R, Body JJ, Brandi ML, Cannata-Andia J, Chappard D, Maghraoui AE, et al. Cancer-associated bone disease. Osteoporos Int. 2013;24:2929\u201353.","journal-title":"Osteoporos Int"},{"key":"2169_CR34","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/00005131-200408000-00013","volume":"18","author":"DJ Jacofsky","year":"2004","unstructured":"Jacofsky DJ, Haidukewych GJ. Management of pathologic fractures of the proximal femur: state of the art. J Orthop Trauma. 2004;18:459\u201369.","journal-title":"J Orthop Trauma"},{"key":"2169_CR35","first-page":"707","volume":"120","author":"RJ Wirbel","year":"1995","unstructured":"Wirbel RJ, Mutschler WE. Surgical therapy of bone metastases. Zentralbl Chir. 1995;120:707\u201315.","journal-title":"Zentralbl Chir"},{"key":"2169_CR36","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3171\/jns.1977.47.5.0653","volume":"47","author":"CA Cobb 3rd","year":"1977","unstructured":"Cobb CA 3rd, Leavens ME, Eckles N. Indications for nonoperative treatment of spinal cord compression due to breast cancer. J Neurosurg. 1977;47:653\u20138.","journal-title":"J Neurosurg"},{"key":"2169_CR37","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1634\/theoncologist.2012-0293","volume":"18","author":"I Laufer","year":"2013","unstructured":"Laufer I, Rubin DG, Lis E, Cox BW, Stubblefield MD, Yamada Y, et al. The NOMS framework: approach to the treatment of spinal metastatic tumors. Oncologist. 2013;18:744\u201351.","journal-title":"Oncologist."},{"key":"2169_CR38","doi-asserted-by":"publisher","first-page":"66","DOI":"10.5603\/NMR.2013.0037","volume":"16","author":"VRD Kakhki","year":"2013","unstructured":"Kakhki VRD, Anvari K, Sadeghi R, Mahmoudian A-S, Torabian-Kakhki M. Pattern and distribution of bone metastases in common malignant tumors. Nucl Med Rev Cent East Eur. 2013;16:66\u20139. https:\/\/doi.org\/10.5603\/NMR.2013.0037.","journal-title":"Nucl Med Rev Cent East Eur"},{"key":"2169_CR39","doi-asserted-by":"publisher","first-page":"11325","DOI":"10.1038\/s41598-017-11700-4","volume":"7","author":"WZ Chen","year":"2017","unstructured":"Chen WZ, Shen JF, Zhou Y, Chen XY, Liu JM, Liu ZL. Clinical characteristics and risk factors for developing bone metastases in patients with breast cancer. Sci Rep. 2017;7:11325.","journal-title":"Sci Rep"},{"key":"2169_CR40","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3892\/ol.2013.1372","volume":"6","author":"T Ibrahim","year":"2013","unstructured":"Ibrahim T, Mercatali L, Amadori D. A new emergency in oncology: bone metastases in breast cancer patients (review). Oncol Lett. 2013;6:306\u201310.","journal-title":"Oncol Lett"},{"key":"2169_CR41","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1186\/s12885-019-6168-1","volume":"19","author":"W Ma","year":"2019","unstructured":"Ma W, Peltzer K, Qi L, Xu G, Liu Z, Wang J, et al. Female sex is associated with a lower risk of bone metastases and favourable prognosis in non-sex-specific cancers. BMC Cancer. 2019;19:1001. https:\/\/doi.org\/10.1186\/s12885-019-6168-1.","journal-title":"BMC Cancer"},{"key":"2169_CR42","doi-asserted-by":"publisher","first-page":"e0159506","DOI":"10.1371\/journal.pone.0159506","volume":"11","author":"W-Y Zhang","year":"2016","unstructured":"Zhang W-Y, Li H-F, Su M, Lin R-F, Chen X-X, Zhang P, et al. A simple scoring system predicting the survival time of patients with bone metastases after RT. PLoS One. 2016;11:e0159506. https:\/\/doi.org\/10.1371\/journal.pone.0159506.","journal-title":"PLoS One"},{"issue":"8","key":"2169_CR43","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1007\/s11605-019-04308-8","volume":"24","author":"S Lei","year":"2019","unstructured":"Lei S, Ge Y, Tian S, Cai B, Gao X, Wang N, et al. Colorectal cancer metastases to brain or bone and the relationship to primary tumor location: a population-based study. J Gastrointest Surg. 2019;24(8):1833. https:\/\/doi.org\/10.1007\/s11605-019-04308-8.","journal-title":"J Gastrointest Surg"},{"key":"2169_CR44","doi-asserted-by":"publisher","first-page":"9104","DOI":"10.1038\/s41598-020-64073-6","volume":"10","author":"D Liu","year":"2020","unstructured":"Liu D, Kuai Y, Zhu R, Zhou C, Tao Y, Han W, et al. Prognosis of prostate cancer and bone metastasis pattern of patients: a SEER-based study and a local hospital based study from China. Sci Rep. 2020;10:9104. https:\/\/doi.org\/10.1038\/s41598-020-64073-6.","journal-title":"Sci Rep"},{"key":"2169_CR45","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10549-011-1721-x","volume":"131","author":"N Sathiakumar","year":"1999","unstructured":"Sathiakumar N, Delzell E, Morrisey MA, Falkson C, Yong M, Chia V, et al. Mortality following bone metastasis and skeletal-related events among women with breast cancer: a population-based analysis of U.S, Medicare beneficiaries. Breast Cancer Res Treat. 1999;131:231\u20138.","journal-title":"Breast Cancer Res Treat"},{"key":"2169_CR46","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1056\/NEJMra030831","volume":"350","author":"GD Roodman","year":"2004","unstructured":"Roodman GD. Mechanisms of bone metastasis. N Engl J Med. 2004;350:1655\u201364.","journal-title":"N Engl J Med"},{"key":"2169_CR47","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1586\/ecp.12.35","volume":"5","author":"A Lipton","year":"2012","unstructured":"Lipton A, Balakumaran A. Denosumab for the treatment of cancer therapy-induced bone loss and prevention of skeletal-related events in patients with solid tumors. Expert Rev Clin Pharmacol. 2012;5:359\u201371.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"2169_CR48","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1053\/clon.2002.0098","volume":"14","author":"P Levack","year":"2002","unstructured":"Levack P, Graham J, Collie D, Grant R, Kidd J, Kunkler I, et al. Don\u2019t wait for a sensory level\u2013listen to the symptoms: a prospective audit of the delays in diagnosis of malignant cord compression. Clin Oncol (R Coll Radiol). 2002;14:472\u201380.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"2169_CR49","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1177\/0300060518770958","volume":"46","author":"R Sevimli","year":"2018","unstructured":"Sevimli R, Korkmaz MF. Analysis of orthopedic surgery of patients with metastatic bone tumors and pathological fractures. J Int Med Res. 2018;46:3262\u20137.","journal-title":"J Int Med Res"},{"key":"2169_CR50","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00520-016-3431-8","volume":"25","author":"NK Behnke","year":"2017","unstructured":"Behnke NK, Baker DK, Xu S, Niemeier TE, Watson SL, Ponce BA. Risk factors for same-admission mortality after pathologic fracture secondary to metastatic cancer. Support Care Cancer. 2017;25:513\u201321. https:\/\/doi.org\/10.1007\/s00520-016-3431-8.","journal-title":"Support Care Cancer"},{"key":"2169_CR51","doi-asserted-by":"publisher","first-page":"4081","DOI":"10.1245\/s10434-014-4002-1","volume":"21","author":"TJ Wood","year":"2014","unstructured":"Wood TJ, Racano A, Yeung H, Farrokhyar F, Ghert M, Deheshi BM. Surgical management of bone metastases: quality of evidence and systematic review. Ann Surg Oncol. 2014;21:4081\u20139. https:\/\/doi.org\/10.1245\/s10434-014-4002-1.","journal-title":"Ann Surg Oncol"},{"key":"2169_CR52","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1634\/theoncologist.2014-0328","volume":"20","author":"Z Wang","year":"2015","unstructured":"Wang Z, Qiao D, Lu Y, Curtis D, Wen X, Yao Y, et al. Systematic literature review and network meta-analysis comparing bone-targeted agents for the prevention of skeletal-related events in cancer patients with bone metastasis. Oncologist. 2015;20:440\u20139. https:\/\/doi.org\/10.1634\/theoncologist.2014-0328.","journal-title":"Oncologist."}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-021-02169-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12957-021-02169-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-021-02169-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T02:03:45Z","timestamp":1614305025000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-021-02169-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,25]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2169"],"URL":"https:\/\/doi.org\/10.1186\/s12957-021-02169-7","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,25]]},"assertion":[{"value":"13 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the local institutional review board (protocol number 224\/16) at the University Medical Center Freiburg, Freiburg, Germany. All studies were performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Each author certifies that he or she has no commercial associations (consultancies, stock ownership, equity interest, patent\/licensing arrangements, etc.) that might pose a conflict of interest in connection with the submitted article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"62"}}